EUVIMEDEUVIMED entdecken
Crossref

IL‐36 signaling pathway dysregulation in Crimean–Congo hemorrhagic fever virus patients: A potential therapeutic avenue

Kübra Doğan iD, Seyit A Büyüktuna

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Kübra Doğan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Sivas Numune Hospital, Sivas, Turkey. Hauptthemen laut MEDLINE: Hemorrhagic Fever Virus, Crimean-Congo, Hemorrhagic Fever, Crimean. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crimean–Congo hemorrhagic fever (CCHF) is a severe viral disease. The scientific literature is growing, emphasizing the significance of the interleukin (IL)‐36 family in the proinflammatory signaling pathway. However, to date, no research has explored the potential of IL‐36 family members as biomarkers in CCHF. This study aims to bridge this gap by evaluating IL‐36α, IL‐36β, and IL‐36γ levels in CCHF patients and healthy controls and investigating their association with disease severity and prognosis. Sixty confirmed CCHF patients and 29 healthy controls were enrolled in this case‐control study. Serum levels of IL‐36α, IL‐36β, and IL‐36γ were measured using enzyme‐linked immunosorbent assays. Significantly higher levels of IL‐36α and IL‐36β were observed in CCHF patients compared to healthy controls ( p < 0.05). However, no statistically significant changes were found in IL‐36γ levels between the two groups. Among the CCHF patients, those who did not survive exhibited significantly elevated IL‐36α and IL‐36γ levels compared to survivors ( p < 0.01). Positive correlations were identified between IL‐36α and IL‐36γ levels with activated partial thromboplastin time, and D‐dimer ( p < 0.01). Conversely, platelet levels showed a negative correlation with IL‐36α and IL‐36γ levels ( p < 0.01). The increased levels of IL‐36α, IL‐36β, and IL‐36γ in patients indicate their participation in proinflammatory reactions in CCHF patients. Understanding the role of IL‐36 family members in CCHF pathogenesis could offer valuable insights into disease progression and facilitate the development of targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever Virus, Crimean-CongoHemorrhagic Fever, CrimeanHumansCase-Control StudiesInterleukinsSignal Transduction

Stichwörter der Autor:innen

Crimean-Congo hemorrhagic fever viruscytokinesinterleukin

Substanzen

Interleukins

Autor:innen und Institutionen

  • Department of Biochemistry, Sivas Numune Hospital, Sivas, Turkey.
  • Department of Infectious Diseases and Clinic Microbiology, School of Medicine, University of Sivas Cumhuriyet, Sivas, Turkey.

ORCID-Profile: Kübra Doğan

Zitieren

APA

Doğan, K., & Büyüktuna, S. A. (2024). IL‐36 signaling pathway dysregulation in Crimean–Congo hemorrhagic fever virus patients: A potential therapeutic avenue. Journal of Medical Virology. https://doi.org/10.1002/jmv.29347

Vancouver

Doğan K, Büyüktuna SA. IL‐36 signaling pathway dysregulation in Crimean–Congo hemorrhagic fever virus patients: A potential therapeutic avenue. Journal of Medical Virology. 2024. doi:10.1002/jmv.29347

BibTeX
@article{Doan2024,
  author = {Doğan, Kübra and Büyüktuna, Seyit A},
  title = {IL‐36 signaling pathway dysregulation in Crimean–Congo hemorrhagic fever virus patients: A potential therapeutic avenue},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29347}
}
Kostenlos starten →